Package 76346-654-03

{"route": ["ORAL"], "spl_id": "4b30c5df-70a3-418c-b2f4-26ab504eb0a3", "openfda": {"nui": ["N0000000115", "N0000175841"], "upc": ["0376346654031"], "unii": ["320T6RNW1F"], "rxcui": ["1245262"], "spl_set_id": ["63c068cd-9370-460f-829b-70e8c7ebe91e"], "pharm_class_epc": ["Progestin Antagonist [EPC]"], "pharm_class_moa": ["Progestational Hormone Receptor Antagonists [MoA]"], "manufacturer_name": ["Corcept Therapeutics Incorporated"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "280 TABLET in 1 BOTTLE (76346-654-03)", "package_ndc": "76346-654-03", "marketing_start_date": "20240528"}], "brand_name": "Mifepristone", "product_id": "76346-654_4b30c5df-70a3-418c-b2f4-26ab504eb0a3", "dosage_form": "TABLET", "pharm_class": ["Progestational Hormone Receptor Antagonists [MoA]", "Progestin Antagonist [EPC]"], "product_ndc": "76346-654", "generic_name": "Mifepristone", "labeler_name": "Corcept Therapeutics Incorporated", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mifepristone", "active_ingredients": [{"name": "MIFEPRISTONE", "strength": "300 mg/1"}], "application_number": "NDA202107", "marketing_category": "NDA", "marketing_start_date": "20240528", "listing_expiration_date": "20261231"}